The activated CD4+ T cell and CD8+ cytotoxic lymphocyte selectively target tumor cells, whereas the glioma cells that do not express the antigen are targeted by activated NK cells, reducing the chance of cancer immune evasion (#NCT02060955) [129]. Here, CD8A is linked to neoplasm.